| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Andrology, Vol 22, Issue 4 604-610, Copyright © 2001 by The American Society of Andrology
JOURNAL ARTICLE |
D. T. Carrell and L. Liu
Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City, USA. dcarrell@med.utah.edu
During the spermatid elongation stage of spermiogenesis approximately 85% of sperm nuclear histones are replaced by protamines. Protamines increase the packing ratio of sperm chromatin, presumably facilitating sperm motility and function. In this study we evaluated the incidence of abnormal protamine expression in 75 patients undergoing in vitro fertilization (IVF) and 50 donors of known fertility by isolation of sperm nuclear proteins, quantitative gel electrophoresis, and Western blot analysis. In addition, we evaluated the relationship between abnormal protamine expression and semen quality, sperm penetration ability, chromatin stability, and IVF outcome. Seventeen percent (13/75) of IVF patients had no measurable protamine 2 (P2) versus 0% (0/50) of donors of known fertility (P < .005). Sperm penetration rates were decreased in 12 of 13 patients without P2, and mean penetration rates (4.6 +/- 1.2 vs 32.8 +/- 2.9, P < .005), normal morphology (22.4 +/- 3.6 vs 48.7 +/- 4.2, P < .05), and progressive motility (22.3 +/- 2.5 vs 35.4 +/- 2.1, P < .05) were all significantly decreased compared with patients with measurable P2. The mean sperm concentration was not significantly different. The presence of protamine precursor bands was also associated with a diminished penetration capacity (18.4 +/- 2.8 vs 36.7 +/- 3.0, P < .05). Sperm chromatin decondensation following exposure to heparin sulfate was significantly increased in patients without a measurable P2 band. Twelve patients with no measurable P2 underwent intracytoplasmic sperm injection (ICSI), with 6 patients (6/12, 50%) becoming pregnant. ICSI fertilization and subsequent embryo cleavage were not different in patients without P2 compared with other patients undergoing ICSI. These data indicate that abnormal sperm protamine levels are a common defect in infertility patients, but not in donors of known fertility. It appears that abnormal protamine levels may reflect defects of late spermiogenesis, including sperm penetration capacity.
This article has been cited by other articles:
 |
|
 |
|
  D. T. Carrell, B. R. Emery, and S. Hammoud Altered protamine expression and diminished spermatogenesis: what is the link? Hum. Reprod. Update, May 1, 2007; 13(3): 313 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Singleton, A. Zalensky, G.F. Doncel, M. Morshedi, and I.A. Zalenskaya Testis/sperm-specific histone 2B in the sperm of donors and subfertile patients: variability and relation to chromatin packaging Hum. Reprod., March 1, 2007; 22(3): 743 - 750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. W. Aoki, B. R. Emery, L. Liu, and D. T. Carrell Protamine Levels Vary Between Individual Sperm Cells of Infertile Human Males and Correlate With Viability and DNA Integrity J Androl, November 1, 2006; 27(6): 890 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. V. Zubkova and B. Robaire Effects of ageing on spermatozoal chromatin and its sensitivity to in vivo and in vitro oxidative challenge in the Brown Norway rat Hum. Reprod., November 1, 2006; 21(11): 2901 - 2910. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Zini and J. Libman Sperm DNA damage: clinical significance in the era of assisted reproduction. Can. Med. Assoc. J., August 29, 2006; 175(5): 495 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. He, W.-Y. Chan, and M. Dym Microarray technology offers a novel tool for the diagnosis and identification of therapeutic targets for male infertility Reproduction, July 1, 2006; 132(1): 11 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Oliva Protamines and male infertility Hum. Reprod. Update, July 1, 2006; 12(4): 417 - 435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhang, M. S. Gabriel, and A. Zini Sperm Nuclear Histone to Protamine Ratio in Fertile and Infertile Men: Evidence of Heterogeneous Subpopulations of Spermatozoa in the Ejaculate J Androl, May 1, 2006; 27(3): 414 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V.W. Aoki, L. Liu, and D.T. Carrell A novel mechanism of protamine expression deregulation highlighted by abnormal protamine transcript retention in infertile human males with sperm protamine deficiency Mol. Hum. Reprod., January 1, 2006; 12(1): 41 - 50. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Zini, J. Meriano, K. Kader, K. Jarvi, C. A. Laskin, and K. Cadesky Potential adverse effect of sperm DNA damage on embryo quality after ICSI Hum. Reprod., December 1, 2005; 20(12): 3476 - 3480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. W. Aoki, S. I. Moskovtsev, J. Willis, L. Liu, J. B. M. Mullen, and D. T. Carrell DNA Integrity Is Compromised in Protamine-Deficient Human Sperm J Androl, November 1, 2005; 26(6): 741 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yoshii, N. Kuji, S. Komatsu, K. Iwahashi, Y. Tanaka, H. Yoshida, A. Wada, and Y. Yoshimura Fine resolution of human sperm nucleoproteins by two-dimensional electrophoresis Mol. Hum. Reprod., September 1, 2005; 11(9): 677 - 681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Mitchell, K. Steger, C. Marchetti, J.-C. Herbaut, P. Devos, and J.-M. Rigot Cellular expression of protamine 1 and 2 transcripts in testicular spermatids from azoospermic men submitted to TESE-ICSI Mol. Hum. Reprod., May 1, 2005; 11(5): 373 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. W. Aoki, L. Liu, and D. T. Carrell Identification and evaluation of a novel sperm protamine abnormality in a population of infertile males Hum. Reprod., May 1, 2005; 20(5): 1298 - 1306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Zini, A. Blumenfeld, J. Libman, and J. Willis Beneficial effect of microsurgical varicocelectomy on human sperm DNA integrity Hum. Reprod., April 1, 2005; 20(4): 1018 - 1021. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bungum, P. Humaidan, M. Spano, K. Jepson, L. Bungum, and A. Giwercman The predictive value of sperm chromatin structure assay (SCSA) parameters for the outcome of intrauterine insemination, IVF and ICSI Hum. Reprod., June 1, 2004; 19(6): 1401 - 1408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Mengual, J. L. Ballesca, C. Ascaso, and R. Oliva Marked Differences in Protamine Content and P1/P2 Ratios in Sperm Cells From Percoll Fractions Between Patients and Controls J Androl, May 1, 2003; 24(3): 438 - 447. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
